| Business Name: |
Jurnalov Catalin D MD |
| Contact Person: |
Catalin Jurnalov |
| Address: |
301 University Boulevard # 3, Galveston, Texas 77555 |
| Phone Number: |
(281) 534-6414 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Jennings John C MD - Galveston, TX 77555
Al-Hendy Ayman MD - Galveston, TX 77555
Couture Susan E MD - Galveston, TX 77555
Austin Jr Arthur MD - Galveston, TX 77555
Borquaye Liliane A MD - Galveston, TX 77555
Daniels Jerry C MD - Galveston, TX 77555
Cowon Daniel MD - Galveston, TX 77555
Leonard Jr Morton H MD - Galveston, TX 77555
Olson Gayle L MD - Galveston, TX 77555
Degroot William J MD - Galveston, TX 77555
Makhlouf Michel A MD - Galveston, TX 77555
Diven Dayna G MD - Galveston, TX 77555
Cesani-Vazquez Fernando MD - Galveston, TX 77555
Lukefahr James L MD - Galveston, TX 77555
Li Husong MD - Galveston, TX 77555
Elkon Deborah MD - Galveston, TX 77555
Lutschg Alexis L MD - Galveston, TX 77555
Culp Jr William C MD - Galveston, TX 77555
Brown Craig D MD - Galveston, TX 77555
Brantley Julie S MD - Galveston, TX 77555
|
The company Jurnalov Catalin D MD provides B2C services in the form of Doctors from its single location in Texas.
1 to 4 employees work for Jurnalov Catalin D MD, and the business now earns $500.000 to $999.999 per annum.
Jurnalov Catalin D MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Jurnalov Catalin D MD, please call Catalin Jurnalov with the phone number (281) 534-6414 or visit its single location at 301 University Boulevard # 3 in Galveston, Texas 77555.
The location of the single location can also be found using the coordinates 29.31176,-94.78233.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.